Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis (Q63359119)
Jump to navigation
Jump to search
scientific article published on 01 February 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis |
scientific article published on 01 February 2007 |
Statements
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis (English)
Emile L E de Bruijne
Sarwa Darwish Murad
Moniek P M de Maat
Elizabeth B Haagsma
Bart van Hoek
Frits R Rosendaal
Harry L A Janssen
Frank W G Leebeek
Liver and Thrombosis Study Group
1 February 2007